New cancer drug begins first human tests in japan
NCT ID NCT06057038
Summary
This early-stage study is testing a new cancer drug called GEN1042 in Japanese patients with advanced solid tumors. Researchers will first give GEN1042 alone to check safety, then test it combined with other cancer drugs. The main goal is to find safe doses and see how the body handles the drug, while also looking for early signs it might help shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cancer Center East
Kashiwa, Japan
-
National Cancer Center Hospital
Tokyo, Japan
-
Tokyo Medical University Hospital
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.